BTAI
BioXcel Therapeutics Inc
Price:  
1.85 
USD
Volume:  
69,682.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BioXcel Stock Forecast & Price Target

BioXcel Stock Price Forecast

The average stock forecast for BioXcel Therapeutics Inc (BTAI) in the next 12 months is 28.05 USD. This price target corresponds to an upside of 1,416.22%. The range of stock forecasts for BioXcel is 1.01 - 84.00 USD. Based on the ratings of 12 analysts, the consensus recommendation for BioXcel is BUY.
Target Low Average Median High
Price (USD) 1.01 28.05 16.32 84.00
Upside -45.41% 1,416.22% 782.16% 4,440.54%

Recommendation Trends

The latest consensus rating for BioXcel is "BUY". This is the average recommendation of 12 analysts: 0 strong sell, 1 sell, 4 hold, 5 buy, 2 strong buy. In the previous period, 12 analysts also majorly recommmended "BUY" for BioXcel.

BioXcel Financial Stock Forecast

Revenue This Year
3.19M
41.00%
from 2.27M
Revenue Next Year
9.50M
197.21%
from 3.19M
EPS This Year
-19.87
82.38%
from -10.90
EPS Next Year
-14.15
-28.77%
from -19.87